English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Financial Venture Capital & PE
Venturi Partners Hits Final Close of USD 175M in Maiden Fund
Apr 26, 2022 11:30 HKT
君联资本联合创建企业朗信生物遗传性视网膜变性基因治疗产品在中国获批临床
Apr 24, 2022 17:02 HKT
君聯資本聯合創建企業朗信生物遺傳性視網膜變性基因治療產品在中國獲批臨床
Apr 24, 2022 17:01 HKT
Legend Capital's Co-founded Company Innostellar Biotherapeutics: IRD Gene Therapy Product was Approved for Clinical Trial in China
Apr 24, 2022 17:00 HKT
Believe Pte raises $55M in Series C funding to continue its global mission of delivering breakthrough personal care and beauty products
Apr 21, 2022 12:48 HKT
Society Pass (SoPa) spins off Leflair to create Leflair Group (LFG), appoints New CEO
Apr 15, 2022 16:00 HKT
XanPay Payment Gateway Accelerates AsiaVape's Local Payments Strategy into Asian Markets
Apr 12, 2022 12:00 HKT
黑桃资本推出首个采用L’OCCITANE en Provence产品的限量版礼品套装
Apr 11, 2022 16:52 HKT
黑桃資本推出首個採用L’OCCITANE en Provence產品的限量版禮品套裝
Apr 11, 2022 16:51 HKT
Black Spade Capital Launches its First Ever Limited Edition Gift Set with L'OCCITANE en Provence Product
Apr 11, 2022 16:50 HKT
TheCapitalNet TV intros Into The Private Markets With Cyril Demaria
Apr 09, 2022 04:00 HKT
君联资本所投创新型疫苗领军企业瑞科生物在港交所成功上市
Apr 07, 2022 16:12 HKT
君聯資本所投創新型疫苗領軍企業瑞科生物在港交所成功上市
Apr 07, 2022 16:11 HKT
Legend Capital's Portfolio Company Recbio Lists on HKEX Successfully
Apr 07, 2022 16:10 HKT
Resintech Bhd Proposes Bonus Share and Warrant Issues
Apr 01, 2022 19:00 HKT
Fullerton Fund Management appoints Ken Goh as Chief Investment Officer
Apr 01, 2022 15:30 HKT
Axis Technologies Group Announces Intention to File Registration Statement for Public Offering of Common Stock
Mar 31, 2022 09:00 HKT
Society Pass (SoPa) Reports Full Year 2021 Financial Results, Sees 891% Year on Year Revenue Growth
Mar 24, 2022 10:00 HKT
Society Pass(SoPa)(社會通行有限公司)公布2021全年财报,收入同比增长891%
Mar 24, 2022 10:00 HKT
Society Pass(SoPa)(社會通行有限公司)公佈2021全年財報,收入同比增長891%
Mar 24, 2022 10:00 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: